Sam Fazeli discusses Eli Lilly acquiring Morphic for $3.2 billion. Mandeep Singh talks about Microsoft and Apple stepping back from OpenAI roles. George Ferguson covers Delta Airlines earnings. Tim Craighead highlights 10 companies to watch in 3Q. Martin Tengler explores the importance of hydrogen in a green future.
Trading Support at Schwab Enhanced by Ameritrade Partnership
Schwab now benefits from specialized support by Ameritrade, offering access to the trade desk for professional answers and live help 24/7 by phone, chat, and in-platform, emphasizing the commitment to assist traders brilliantly.
Importance of Seeking Partners with Complementary Skills in Business
Success in business often involves partnering with individuals possessing skills or knowledge that one lacks. Lenovo's Lenovo Pro online membership program aids small businesses by offering tech support and expertise, highlighting the value of collaborating with partners to enhance business capabilities.
Eli Lilly's Acquisition of Morphic to Strengthen Immunology Franchise
Eli Lilly's $3.2 billion acquisition of Morphic focuses on bolstering their immunology franchise, targeting disease areas such as arthritis, psoriasis, Crohn's disease, and inflammatory bowel disease. The move reflects a strategic expansion to address unmet medical needs in the immunology and inflammation field.
Pharmaceutical Companies' Strategic Approach in M&A Deals
Around 30-40% of pharmaceutical companies' pipelines are fueled by M&A deals or strategic partnerships to enhance their therapeutic offerings. Eli Lilly's consistent acquisition strategy in various therapeutic areas, including inflammation, signifies a common industry trend towards targeted acquisitions for drug development and innovation.
Delta Airlines Earnings Report Indicates Challenges in Filling Flights
Delta Airlines reports quarter results highlighting challenges in filling economy class seats amid corporate travel volume growth. The aviation industry's struggle to yield higher fares and fill flights, compounded by tough revenue comps, signals a challenging market outlook for airlines such as Delta during the ongoing recovery period.
On this week’s podcast: Sam Fazeli, Bloomberg Intelligence Director of Research for Global Industries and Senior Pharmaceuticals, discusses Eli Lilly agreeing to buy U.S. gut-drug maker ‘Morphic’ for about $3.2 billion. Mandeep Singh, Bloomberg Intelligence Senior Tech Industry Analyst, talks about Microsoft and Apple dropping plans to take board roles at OpenAI. George Ferguson, Bloomberg Intelligence Senior Aerospace, Defense, and Airlines Analyst, discusses Delta Airlines earnings. Tim Craighead, Bloomberg Intelligence Global Chief Content Officer, talks about research on 10 companies to watch for in 3Q. Martin Tengler, Bloomberg BNEF Head of Hydrogen Research, discusses hydrogen, and why it’s important as we move towards a green future.
The Bloomberg Intelligence radio show with Paul Sweeney and Alix Steel podcasts through Apple’s iTunes, Spotify and Luminary. It broadcasts on Saturdays and Sundays at noon on Bloomberg’s flagship station WBBR (1130 AM) in New York, 106.1 FM/1330 AM in Boston, 99.1 FM in Washington, 960 AM in the San Francisco area, channel 121 on SiriusXM, www.bloombergradio.com, and iPhone and Android mobile apps. Bloomberg Intelligence, the research arm of Bloomberg L.P., has more than 400 professionals who provide in-depth analysis on more than 2,000 companies and 135 industries while considering strategic, equity and credit perspectives. BI also provides interactive data from over 500 independent contributors. It is available exclusively for Bloomberg Terminal subscribers.